Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
7.95
-0.13 (-1.61%)
Jul 18, 2025, 4:00 PM EDT
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 13.74B EUR in the quarter ending March 31, 2025, a decrease of -0.20%. This brings the company's revenue in the last twelve months to 46.58B, down -0.92% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.58B EUR
Revenue Growth
-0.92%
P/S Ratio
0.63
Revenue / Employee
507.04K EUR
Employees
91,864
Market Cap
31.68B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Bayer Aktiengesellschaft News
- 2 days ago - Cory Booker pitches bill to allow lawsuits against pesticide makers over ‘toxic products’ - The Guardian
- 3 days ago - Bayer AG extends contract of CEO Bill Anderson - Seeking Alpha
- 3 days ago - Bayer extends contract of CEO until March 2029 - Reuters
- 3 days ago - Bayer: Upside Compelling - Buy - Seeking Alpha
- 5 days ago - Environmentalists object to Punjab govt’s NoC for genetically modified (GM) maize trials; coalition demands inquiry - The Times of India
- 9 days ago - Bayer gets UK nod for menopausal hot flash therapy - Seeking Alpha
- 10 days ago - Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy - Reuters
- 18 days ago - Bayer Appoints Priyal Patel as Chief Financial Officer for North America - Business Wire